I am not concerned about history. What is going on over the past year ? And what can happen to change going forward ? I use Merck as a point of interest as it was always the poster child for patent expirations. Even Pfizer seems to have overcome it's patent loss. There have been no major negatives other than the Chinese nutrition stuff and that did not seem anything like the major negative penalties of the past. Is Abbott still the growth stock it was in the past ?
How about since 2000??? Without the financial engineering to separate into two companies and the one time price bump, you are left with a company that has been repeatedly tagged with huge fines and a loss in business potential that is hard to quantify. And for this we should be happy???